Excerpt -----
“We’re delighted to see very strong support from the market,” Biotron boss Dr Michelle Miller told *.
The test results were “a major step to the ultimate goal of curing HIV-1 infection”, Dr Miller said.
But Biotron will need funding to progress to the next stage — and that means finding a partner if the biotech wants to avoid going back to the market for more cash.
DYOR
BIT Chart, page-114
-
- There are more pages in this discussion • 567 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
